These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
571 related items for PubMed ID: 26393895
1. Refractive Error in Patients with Retinopathy of Prematurity after Laser Photocoagulation or Bevacizumab Monotherapy. Kuo HK, Sun IT, Chung MY, Chen YH. Ophthalmologica; 2015; 234(4):211-7. PubMed ID: 26393895 [Abstract] [Full Text] [Related]
2. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis. Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR. Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024 [Abstract] [Full Text] [Related]
9. Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser. Isaac M, Mireskandari K, Tehrani N. J AAPOS; 2015 Apr; 19(2):140-4. PubMed ID: 25892041 [Abstract] [Full Text] [Related]
10. Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for Treatment of Type 1 Retinopathy of Prematurity in Turkish Preterm Children. Kabataş EU, Kurtul BE, Altıaylık Özer P, Kabataş N. Curr Eye Res; 2017 Jul; 42(7):1054-1058. PubMed ID: 28128986 [Abstract] [Full Text] [Related]
11. Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone. Mueller B, Salchow DJ, Waffenschmidt E, Joussen AM, Schmalisch G, Czernik C, Bührer C, Schunk KU, Girschick HJ, Winterhalter S. Br J Ophthalmol; 2017 Mar; 101(3):365-370. PubMed ID: 27301450 [Abstract] [Full Text] [Related]
13. Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. Chen YH, Chen SN, Lien RI, Shih CP, Chao AN, Chen KJ, Hwang YS, Wang NK, Chen YP, Lee KH, Chuang CC, Chen TL, Lai CC, Wu WC. Eye (Lond); 2014 Sep; 28(9):1080-6; quiz 1087. PubMed ID: 25104736 [Abstract] [Full Text] [Related]
15. Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. Anand N, Blair MP, Greenwald MJ, Rodriguez SH. J AAPOS; 2019 Apr; 23(2):88.e1-88.e6. PubMed ID: 30797978 [Abstract] [Full Text] [Related]
16. Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation. Wiecek E, Akula JD, Vanderveen DK, Mantagos IS, Wu C, Curran AL, De Bruyn H, Peterson B, Fulton AB. Am J Ophthalmol; 2022 Aug; 240():252-259. PubMed ID: 35367438 [Abstract] [Full Text] [Related]
17. One-year refractive outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity. Kıran Yenice E, Petriçli İS, Kara C. Int Ophthalmol; 2023 Jul; 43(7):2197-2202. PubMed ID: 36522564 [Abstract] [Full Text] [Related]
18. Comparison of 5-year safety and efficacy of laser photocoagulation and intravitreal bevacizumab injection in retinopathy of prematurity. Murakami T, Sugiura Y, Okamoto F, Okamoto Y, Kato A, Hoshi S, Nagafuji M, Miyazono Y, Oshika T. Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2849-2855. PubMed ID: 33744981 [Abstract] [Full Text] [Related]
19. RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY. Ling KP, Liao PJ, Wang NK, Chao AN, Chen KJ, Chen TL, Hwang YS, Lai CC, Wu WC. Retina; 2020 Sep; 40(9):1793-1803. PubMed ID: 31800460 [Abstract] [Full Text] [Related]
20. Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes. Futamura Y, Asami T, Nonobe N, Kachi S, Ito Y, Sato Y, Hayakawa M, Terasaki H. Jpn J Ophthalmol; 2015 Nov; 59(6):378-88. PubMed ID: 26265249 [Abstract] [Full Text] [Related] Page: [Next] [New Search]